Short answer · Medically reviewed summary · Last updated: 2026-05-08
Currently, there is no medical cure for Familial Adenomatous Polyposis (FAP), a genetic condition characterized by the development of hundreds to thousands of colorectal polyps. While no cure exists, management strategies—primarily prophylactic surgery—are highly effective at preventing the nearly inevitable progression to colorectal cancer, allowing individuals with Familial Adenomatous Polyposis to live long, productive lives. How is Familial Adenomatous Polyposis currently managed? Because Familial Adenomatous Polyposis is caused by mutations in the APC gene, the primary goal of care is risk reduction.
3 people with Familial Adenomatous Polyposis have shared their first-person experience on this question at DiseaseMaps.
Currently, there is no medical cure for Familial Adenomatous Polyposis (FAP), a genetic condition characterized by the development of hundreds to thousands of colorectal polyps. While no cure exists, management strategies—primarily prophylactic surgery—are highly effective at preventing the nearly inevitable progression to colorectal cancer, allowing individuals with Familial Adenomatous Polyposis to live long, productive lives.
Because Familial Adenomatous Polyposis is caused by mutations in the APC gene, the primary goal of care is risk reduction. Standard management includes:
Researchers are investigating precision medicine to address the root cause of Familial Adenomatous Polyposis. Cutting-edge approaches include gene-editing technologies like CRISPR-Cas9, which aim to correct the APC mutation, and mRNA-based therapies. Additionally, clinical trials are exploring targeted immunotherapies and personalized vaccines designed to help the immune system identify and destroy pre-malignant cells before they develop into tumors.
While experimental gene therapies are showing promise in laboratory settings, clinical application remains in the early stages. Most experts suggest that while we are unlikely to see a "one-pill" cure in the next few years, advancements in precision medicine will likely lead to less invasive, more personalized treatments within the next decade. Patients with Familial Adenomatous Polyposis are encouraged to monitor resources like ClinicalTrials.gov to track ongoing, active studies.
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.